N-Nitroso Fedratinib Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Fedratinib is used to treat adults with certain types of myelofibrosis (MF; a cancer of the bone marrow in which the bone marrow is replaced by scar tissue and causes decreased blood cell production). Fedratinib is in a class of medications called kinase inhibitors.N-Nitroso Fedratinib Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Fedratinib Impurity 1 CAS NO:NA Chemically represented as N-(Tert-butyl)-3-((5-methyl-2-(nitroso(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl) (nitroso) amino) benzenesulfonamide .Synchemia is the leading manufacturing and exporter of N-Nitroso Fedratinib Impurity 1.We supply N-Nitroso Fedratinib Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142003 |
| CAS No | 69091-16-3 |
| Mol.F. | C6H12N2O2 |
| Mol.Wt. | 144.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142004 |
| CAS No | 6972-76-5 |
| Mol.F. | C5H12N4O2 |
| Mol.Wt. | 160.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142005 |
| CAS No | 6943-40-4 |
| Mol.F. | C6H8N4O6 |
| Mol.Wt. | 232.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142006 |
| CAS No | NA |
| Mol.F. | C6H10N2O3S |
| Mol.Wt. | 190.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142007 |
| CAS No | 68061-82-5 |
| Mol.F. | C9H10N2O3 |
| Mol.Wt. | 194.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142008 |
| CAS No | 89166-19-8 |
| Mol.F. | C4H9ClN2O |
| Mol.Wt. | 136.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142009 |
| CAS No | 760-60-1 |
| Mol.F. | C5H11N3O2 |
| Mol.Wt. | 145.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142010 |
| CAS No | 64005-62-5 |
| Mol.F. | C8H16N2O3 |
| Mol.Wt. | 188.2 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142011 |
| CAS No | NA |
| Mol.F. | C12H10ClN3O |
| Mol.Wt. | 247.7 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142012 |
| CAS No | NA |
| Mol.F. | C4H11N3O |
| Mol.Wt. | 117.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142013 |
| CAS No | 36972-73-3 |
| Mol.F. | C9H12N2O2 |
| Mol.Wt. | 180.2 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142014 |
| CAS No | 16339-16-5 |
| Mol.F. | C3H7ClN2O |
| Mol.Wt. | 122.6 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142015 |
| CAS No | NA |
| Mol.F. | C7H13N3O2 |
| Mol.Wt. | 171.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142016 |
| CAS No | 1116-82-1 |
| Mol.F. | C6H8N4O |
| Mol.Wt. | 152.2 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142017 |
| CAS No | NA |
| Mol.F. | C6H6ClN3O |
| Mol.Wt. | 171.58 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142018 |
| CAS No | NA |
| Mol.F. | C13H11ClN4O2 |
| Mol.Wt. | 290.71 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |